FDA Discussion Paper on Generative AI in Medical Devices: Feedback Deadline and Key Considerations

This episode details the US FDA's discussion paper on regulating medical devices incorporating Generative Artificial Intelligence (GenAI), released on August 18, 2026. We cover the key areas where the FDA is seeking input, including risk assessment, premarket evaluation, and postmarket monitoring for GenAI-enabled devices. We also emphasize the critical October 19, 2026, deadline for submitting feedback and provide practical steps for manufacturers to prepare and respond. Key Questions: - What is the FDA's new discussion paper on Generative AI in medical devices? - Why is the FDA seeking public feedback before issuing guidance? - What are the key risk assessment challenges for GenAI-enabled devices? - How might premarket submission requirements change for these products? - What postmarket surveillance obligations is the FDA considering? - Who is affected by this new regulatory exploration? - What is the deadline for submitting comments to the FDA? - What practical steps should regulatory and R&D teams take right now? - How does GenAI differ from traditional AI/ML in the eyes of regulators? Sources: - https://www.fda.gov/news-events/press-announcements/fda-seeks-public-feedback-inform-regulatory-approach-generative-ai-enabled-medical-devices - https://www.fda.gov/medical-devices/digital-health-center-excellence/considerations-regulation-generative-ai-enabled-medical-devices-discussion-paper-and-request-feedback How Pure Global can help: Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We help you develop efficient regulatory strategies and prepare technical dossiers for submission to authorities like the FDA, especially for novel technologies like AI/ML and GenAI. Our experts can help you analyze new discussion papers, formulate feedback, and perform gap analyses to ensure your quality and development processes are aligned with future requirements. With a presence in over 30 markets, we streamline global market access. Learn more about our AI-powered tools and global database at https://pureglobal.ai, or contact us at [email protected] and https://pureglobal.com.